COVID-19 and Dermal Fillers: Should We Really Be Concerned?

Area of Science:

• Dermatology
• Immunology
• Infectious Diseases

Background:

• SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has caused a global health crisis with significant mortality.
• Delayed inflammatory reactions to hyaluronic acid dermal fillers have been observed post-SARS-CoV-2 infection and vaccination.
• These reactions, though often self-limiting, are classified as serious adverse events by regulatory bodies.

Purpose of the Study:

• To investigate the occurrence and characteristics of delayed inflammatory reactions to hyaluronic acid dermal fillers in the context of SARS-CoV-2.
• To highlight the potential immune-mediated mechanisms underlying these filler complications.
• To emphasize the need for physician reporting and further research into long-term effects.

Main Methods:

• Case reports and clinical observations of patients experiencing delayed inflammatory reactions to hyaluronic acid fillers.
• Analysis of potential triggers, including SARS-CoV-2 infection and vaccination.
• Review of diagnostic and treatment strategies for these adverse events.

Main Results:

• Delayed inflammatory reactions manifest primarily in facial hyaluronic acid fillers.
• Reactions appear to be type IV hypersensitivity responses, potentially triggered by viral presence.
• While generally not severe, these events necessitate medical evaluation and management with corticosteroids, hyaluronidase, or antibiotics.

Conclusions:

• Delayed inflammatory reactions to hyaluronic acid fillers are a recognized complication associated with SARS-CoV-2 infection and vaccination.
• Understanding the immunological mechanisms is crucial for managing these events and potentially preventing future occurrences.
• Long-term studies on filler materials and increased physician reporting are essential given the evolving pandemic and ongoing use of aesthetic injectables.